|
|
Current Management of Acute Bronchitis in Ambulatory CareThe Use of Antibiotics and Bronchodilators
Arch G. Mainous III, PhD;
Roger J. Zoorob, MD;
William J. Hueston, MD
Arch Fam Med. 1996;5(2):79-83.
References Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Verheij TJM, Kaptein AA, Mulder JD. Acute bronchitis: aetiology, symptoms and treatment. Fam Pract. 1989;6:66-69.
FREE FULL TEXT
2. Boldy DA, Skidmore SJ, Ayres JG. Acute bronchitis in the community: clinical features, infective factors, changes in pulmonary function and bronchial activity to histamine. Respir Med. 1990;84:377-385.
PUBMED
3. Orr PT, Scherer K, McDonald A, Moffatt M. Randomized placebo-controlled trials of antibiotics for acute bronchitis: a critical review of the literature. J Fam Pract. 1993;36:507-512.
PUBMED
4. Trigg CJ, Davies RI. Antibiotic prescribing for bronchitis: time for a change? Respir Med. 1994;88:161-163.
PUBMED
5. Gonzales R, Sande M. What will it take to stop physicians from prescribing antibiotics in acute bronchitis? Lancet. 1995;345:665.
PUBMED
6. Franks P, Uleiner JA. The treatment of acute bronchitis with trimethoprim and sulfamethoxazole. J Fam Pract. 1984;19:185-190.
PUBMED
7. Verheij TJM, Hermans J, Kaptein AA, Mulder JD. Acute bronchitis: general practitioners' views regarding diagnosis and treatment. Fam Pract. 1990;7:175-180.
FREE FULL TEXT
8. Burns JL. Mechanisms of bacterial resistance. Pediatr Clin North Am. 1995;42:497-507.
PUBMED
9. Ballow CH, Schentag JJ. Trends in antibiotic utilization and bacterial resistance: report of the National Nosocomial Resistance Surveillance Group. Diagn Microbiol Infect Dis. 1992;15(suppl_2):375-425.
PUBMED
10. North D. Controlling the costs of antibiotic resistance. Clin Ther. 1993;15 (suppl A):3-11.
PUBMED
11. Bartlett JG, Froggatt JW III. Antibiotic resistance. Arch Otolaryngol Head Neck Surg. 1995;121:392-396.
FREE FULL TEXT
12. Molstad S, Ekedahl A, Hovelius B, Thimansson H. Antibiotics prescription in primary care: a 5-year follow-up of an educational program. Fam Pract. 1994;11:282-286.
FREE FULL TEXT
13. Applebaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis. 1992;15:95-99.
PUBMED
14. Mufson MA. Viral acute pharyngitis, laryngitis, bronchitis. In: Wingaarden JB, Smith LH Jr, Bennett JC, eds. Cecil's Textbook of Medicine. Philadelphia, Pa: WB Saunders Co; 1992:1810-1811. 15. Hueston WJ. A comparison of albuterol and erythromycin for the treatment of acute bronchitis. J Fam Pract. 1991;33:476-480.
PUBMED
16. Melbye H, Aasebo U, Straume B. Symptomatic effect of inhaled fenoterol in acute bronchitis: a placebo-controlled double-blind study. Fam Pract. 1991;8:216-222.
FREE FULL TEXT
17. Hueston WJ. Albuterol metered-dose inhaler in the treatment of acute bronchitis. J Fam Pract. 1994;39:437-440.
PUBMED
18. Williamson HA Jr. Pulmonary function tests in acute bronchitis: evidence for reversible airway obstruction. J Fam Pract. 1987;25:251-256.
PUBMED
19. St. Anthony's Color-Coded ICD-9-CM Book for Physician Payment. 1994 edition. Alexandria, Va: St Anthony Publishing Inc; 1993;1, 2. 20. Saint S, Bent S, Vittinghoff E, Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations: a meta-analysis. JAMA. 1995;273:957-960.
FREE FULL TEXT
21. Dee C, Blazek R. Information needs of the rural physician: a descriptive study. Bull Med Libr Assoc. 1993;81:259-264.
PUBMED
22. Sanders J, Brucker P, Miller MD. Using telemedicine for continuing education for rural physicians. Acad Med. 1995;70:457.
PUBMED
23. Halfon N, Newacheck PW. Childhood asthma and poverty: differential impacts and utilization of health services. Pediatrics. 1993;91:56-61.
FREE FULL TEXT
24. Hueston WJ, Schiaffino MA. Antibiotic choice and patient outcomes in communityacquired pneumonia. J Am Board Fam Pract. 1994;7:95-99.
PUBMED
25. Barry AL, Jones RN. In vitro activity of ciprofloxacin against gram positive cocci. Am J Med. 1987;82(suppl 4A):27-32.
PUBMED
26. Korner RI, Reeves DS, MacGowan AP. Dangers of oral fluoroquinolone treatment in community acquired upper respiratory tract infections. BMJ. 1994;308:191-192.
FREE FULL TEXT
27. Little PS, Williamson I. Are antibiotics appropriate for sore throats? costs outweigh the benefits. BMJ. 1994;309:1010-1011.
FREE FULL TEXT
28. Baquero F, Loza E. Antibiotic resistance of microorganisms involved in ear, nose and throat infections. Pediatr Infect Dis J. 1994;13:S9-S14.
PUBMED
29. Eliasson I, Holst E, Kamme C. Molstad S. Emergence and persistence of betalactamase-producing bacteria in the upper respiratory tract in children treated with beta-lactam antibiotics. Am J Med. 1990;88:S51-S55.
PUBMED
30. Vinson DC, Lutz LJ. The effect of parental expectations on the treatment of children with a cough: a report from ASPN. J Fam Pract. 1993;37:23-27.
PUBMED
31. Pozzi E. Clinical efficacy of dirithromycin versus miomyacin in the treatment of acute bronchitis or acute exacerbations of chronic bronchitis. J Antimicrob Chemother. 1993;31(suppl C):153-158.
FREE FULL TEXT
32. Psalty BM, Koepsell TD, Yanez D, et al. Temporal patterns of antihypertensive medication use among older adults, 1989 through 1992: an effect of the major clinical trials on clinical practice? JAMA. 1995;273:1436-1438.
FREE FULL TEXT
33. Molstad S, Arvidsson E, Eliasson I, et al. Production of beta-lactamase in respiratory tract bacteria in children: relationship to antibiotic use. Scand J Prim Health Care. 1992;10:16-20.
PUBMED
|